Amid shortage, Accord Healthcare restarts production of cancer drug cisplatin

SourceFierce Pharma
Date Published11/16/2023
Author NameJoseph Keenan

Additional Reshoring Information:

Company/Division name Accord Healthcare
Parent companyIntas Pharmaceuticals
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2023
Year reshoring implemented or to be implemented:2023
Country(ies) from which reshored:India
City reshored to:Durham
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredcancer drug cisplatin
Find Reshoring Articles